Read more

May 12, 2020
2 min read
Save

Most patients consumed no more than five opioid pills after knee arthroscopy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Most patients who underwent knee arthroscopy consumed no more than five opioid pills postoperatively, according to published results.

Perspective from Jourdan M. Cancienne, MD
Paul M. Sethi
Paul M. Sethi

Paul M. Sethi, MD, and colleagues queried 100 patients who underwent knee arthroscopy between May 2018 and May 2019 on total postoperative opioid consumption, preoperative opioid consumption, smoking status and history of depression. Researchers determined the total number of opioids prescribed and number of refills according to each patient’s chart, and reviewed state databases for additional opioid prescriptions.

Results showed a median of five oxycodone 5-mg pills were prescribed to patients postoperatively. Researchers found patients had a median postoperative opioid consumption of zero pills and a mean of 1.9 pills. Patients consumed between zero to 25 pills of oxycodone 5 mg, according to results.

Results showed 90% of all patients consumed less than 5 opioid pills after knee arthroscopy.
Results showed 90% of all patients consumed less than 5 opioid pills after knee arthroscopy.

Researchers noted 97% of patients did not obtain refills. Results showed 58% of patients did not consume any opioids and 90% of all patients consumed less than five pills. Sethi noted the results of this study are in contrast to expert panel guidelines that recommend prescription of 12 to 30 opioid pills. Smoking, depression and prior opioid use did not affect postoperative opioid consumption, according to results.

“Orthopedic surgeons need to continue to lead the charge on reducing opiate dependence after surgery,” Sethi told Healio Orthopedics. “This reduction in medication prescribed can translate directly in fewer excess medications prescribed and reduces the risk of misused or diverted medication.” – by Casey Tingle

 

Disclosures: Sethi reports he is a consultant for Pacira Pharmaceuticals, Arthrex and Flexion Therapeutics; and is an assistant editor for the Journal of Shoulder and Elbow Surgery. Please see the study for all other authors’ relevant financial disclosures.